Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver

被引:37
作者
Sun, YN
DuBois, DC
Almon, RR
Pyszczynski, NA
Jusko, WJ [1 ]
机构
[1] SUNY Buffalo, Dept Pharmaceut, Sch Pharm, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1998年 / 26卷 / 06期
关键词
methylprednisolone; pharmacokinetics; pharmacodynamics; indirect pharmacodynamic response models; glucocorticoid receptor; Northern hybridization; mRNA; down-regulation; tyrosine aminotransferase; dose dependence; tolerance;
D O I
10.1023/A:1020746822634
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dose-dependent and repeated-dose effects of methylprednisolone (MPL) on down-regulation of glucocorticoid receptor messenger RNA (GR mRNA) and GR density, as well as thyrosine amino-transferase (TAT) mRNA and TAT induction by receptor/gene-mediated mechanisms in rat liver were examined. A previously developed pharmacokinetic/pharmacodynamic (PK/PD) model was used to design these studies which sought to challenge the model. Three groups of male adrenalectomized Wistar rats received MPL by iv injection: low-dose (10 mg/kg at Time 0), high-dose (50 mg/kg at Time 0), and dual-dose (50 mg/kg at Time 0 and 24 hr). Plasma concentrations of MPL, and hepatic content of free GR, GA mRNA, TAT mRNA, and TAT activity were determined. The P-Pharm program was applied for population analysis of MPL PK repealing low interindividual variation in CL and V-c values (3-14%). Two indirect response models were applied to test two competing hypotheses for GR mRNA dynamics. Indirect Pharmacodynamic Response Model I(Model A) where the complex in the nucleus decreases the transcription rate of GR mRNA better described GR mRNA/GR down-regulation. Levels of TAT, mRNA began to increase at 1-2 hr, reached a maximum at 5-6 hr, and declined to the baseline at 12-14 hr after MPL dosing. The induction of TAT activity followed a similar pattern with a delay of about 1-2 hr. The low-dose group had 50-60% of the TA T mRNA and TAT induction compared to the high-dose group. Since the GR density returned to about 70% of the baseline level before the second 50 mg/kg dose at 24 hr, tolerance was found for TAT mRNA/TAT induction where only 50-60% of the initial responses were produced Our fourth-generation,model describes the dose dependence and tolerance effects of TAT mRNA/TAT induction by MPL involving multiple-step signal transduction controlled by the steroid regimen, free GR density, and GR occupancy. This model,may, provide the foundation for similar ping other induced proteins or enzymes mediated by the similar; receptor/nuclear events.
引用
收藏
页码:619 / 648
页数:30
相关论文
共 58 条
[1]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[2]   TESTING FOR THE EQUALITY OF AREA UNDER THE CURVES WHEN USING DESTRUCTIVE MEASUREMENT TECHNIQUES [J].
BAILER, AJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1988, 16 (03) :303-309
[3]   PHARMACODYNAMIC MODELS OF NITROGLYCERIN-INDUCED HEMODYNAMIC TOLERANCE IN EXPERIMENTAL HEART-FAILURE [J].
BAUER, JA ;
FUNG, HL .
PHARMACEUTICAL RESEARCH, 1994, 11 (06) :816-823
[4]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[5]   THE POLY(A)-POLY(A)-BINDING PROTEIN COMPLEX IS A MAJOR DETERMINANT OF MESSENGER-RNA STABILITY INVITRO [J].
BERNSTEIN, P ;
PELTZ, SW ;
ROSS, J .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) :659-670
[6]   RECEPTOR-MEDIATED PHARMACODYNAMICS OF PREDNISOLONE IN THE RAT [J].
BOUDINOT, FD ;
DAMBROSIO, R ;
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1986, 14 (05) :469-493
[7]   GLUCOCORTICOID THERAPY FOR IMMUNE-MEDIATED DISEASES - BASIC AND CLINICAL CORRELATES [J].
BOUMPAS, DT ;
CHROUSOS, GP ;
WILDER, RL ;
CUPPS, TR ;
BALOW, JE .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (12) :1198-1208
[8]   PHARMACOKINETICS OF REVERSIBLE METABOLIC SYSTEMS [J].
CHENG, HY ;
JUSKO, WJ .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1993, 14 (09) :721-766
[9]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[10]  
COONEY AJ, 1994, MECHANISM STEROID HO, P25